Analytics & value-based care
Clinical Research Analytics Software
Enrollment, per-study margin, unbilled sponsor work and trial-claim failures in one place, with each number traced back to the visits behind it.
Clinical Research Analytics Software shows how each study is doing as a business: enrollment against target, screen failures, revenue earned against the budget, sponsor money still owed, and how often trial claims come back. Numbers drill down to the participant, visit and claim, so leaders can see why a study's margin moved, not just that it did.


Analytics in a Clinical Research Practice
A research site needs two kinds of numbers that most practice tools keep apart. One set is operational: participants screened, enrolled and active, visits done inside their windows, and the age of charges waiting in research billing review. The other set is financial: sponsor revenue earned and invoiced, insurance revenue for routine care, holdbacks, and refunds owed. Unlimited Systems builds both from the same posted data, so a drop in margin can be traced to its cause. Maybe screen failures rose and the budget pays less for them. Maybe completed visits weren't invoiced, or Medicare returned a batch of claims missing the NCT number. Analytics compares each study with its own budget and with the site's other studies, by sponsor, investigator and payer. Trends show which sponsors pay slowly and which protocols cost more coordinator time than the budget assumed, before the next agreement is signed.
Why Is Analytics Different in Clinical Research?
Study margin is hard to see because the revenue comes in pieces. Per-visit payments, screen-failure fees, start-up fees and pass-through costs arrive from the sponsor on their own schedules. Routine care on the same participants pays through insurance. Analytics that only reads claims misses most of the sponsor side, and a spreadsheet kept by the research office misses the insurance side. Neither shows the whole study.
Enrollment drives almost everything else. A study that screens many people but enrolls few can lose money even when every visit is billed, if the budget pays little for screen failures. A study that enrolls well but lets visits fall outside their windows may lose sponsor payments for those visits. Tracking screening, enrollment and window compliance next to revenue shows which problem a study actually has.
Compliance signals belong in the same view. A rise in claims Medicare returns for missing trial data, or in services paid by both sponsor and insurer, is a billing problem and an audit risk at once. Routine-cost denials from commercial or Medicaid plans may point to a payer that is misreading trial status. Research analytics should show these next to the money, so they are fixed while the study is still open.
What Clinical Research Analytics Software Handles
- Trial-claim return rate
- Medicare returns claims missing the NCT number with CARC 16, MA50 and MA130, and Q1 claims missing Z00.6 with CARC 16 and M76. Returns are counted by study and by error, so a setup gap shows up after a few claims, not a full quarter. (CMS Medicare Claims Processing Manual, Chapter 32, Section 69: Qualifying Clinical Trials)
- Routine-cost denials by payer
- Most group and individual plans may not deny routine patient costs for a qualified participant in an approved trial. Denials that cite trial status are tallied by payer and plan, which shows where appeals and payer outreach are worth the effort. (42 U.S.C. 300gg-8: Coverage for individuals participating in approved clinical trials)
- Medicaid trial coverage outcomes
- State Medicaid programs must cover routine costs in qualifying trials and may not deny them because the trial is out of state or out of network. Medicaid outcomes are tracked by state and managed care plan for studies that enroll Medicaid patients. (CMS State Medicaid Director Letter 21-005: Mandatory Medicaid Coverage of Routine Patient Costs in Qualifying Clinical Trials)
- Medicare Advantage participants
- For qualifying trials, Original Medicare pays routine costs for Medicare Advantage enrollees, while IDE studies are paid by the plan. Payer mix by study separates those groups, so expected payer and actual payer can be compared. (CMS Medicare Managed Care Manual, Chapter 4, Section 10.7: Clinical Trials)
- Coverage with Evidence Development studies
- Under CED, CMS covers some items only in the context of an approved study. Services billed under a CED national coverage determination are counted with their study number, so volume and payment can be seen by NCD. (CMS: Coverage with Evidence Development)
How Does Clinical Research Analytics Software Work?
1. Load each study's budget
The budget's per-visit rates, invoiceable items and fees are set up for each study. Every visit and item then has an expected value to measure against.
2. Join operations to money
Screening, enrollment and visit data from the study calendar sit next to charges, claims and sponsor receipts. Each research KPI is built from records staff can open and check.
3. Watch earned but unbilled work
Visits done but not yet invoiced to the sponsor are counted as earned and unbilled, like unbilled accounts receivable on the claim side. A growing balance points to a gap in sponsor invoicing.
4. Explain what moved
When margin, enrollment or the return rate changes, analytics breaks it down by sponsor, investigator, payer and visit type. Leaders see the cause before they see a total.
5. Share the findings
Study trends go to leaders as scheduled research reports and to staff as study dashboards. Each view keeps the drill-down to the underlying visits and claims.
Clinical Research Analytics Software vs. Generic Software
| Area | Generic approach | Unlimited Systems |
|---|---|---|
| Study margin | Guessed from sponsor checks received. | Earned sponsor and insurance revenue measured against the budget, by study. |
| Enrollment | Tracked by the research office in a separate tool. | Screening, enrollment and window compliance shown beside revenue. |
| Unbilled sponsor work | Found at close-out. | Earned but uninvoiced visits counted by study as they happen. |
| Trial-claim failures | Mixed into the overall denial rate. | Returns and routine-cost denials counted by study, payer and error. |
| Sponsor payment speed | Known by feel. | Payment timing trended by sponsor and CRO. |
Who Uses It in a Clinical Research Practice
- Research director: A view of every study's enrollment, margin and open sponsor balance, with the drill-down to see why a study is off track.
- Billing manager: Trial-claim returns and routine-cost denials by study and payer, so fixes reach the claim setup that caused them.
- Physician owner: Evidence of which studies, sponsors and protocol types pay their way, before the practice signs the next agreement.
Clinical Research Analytics Software FAQs
The analytics that matter most join operations to money. Enrollment against target, screen failures and visits inside their windows sit next to revenue earned against the budget, unbilled sponsor work and sponsor balances. Trial-claim returns and routine-cost denials round it out. Together they show whether a study is short on participants, short on billing, or short on payment.
Per-study margin compares what a study earned with what it cost. Earned revenue includes sponsor payments for visits, screen failures and fees, plus insurance payments for routine care. Costs include pass-through fees and the coordinator and investigator time the site tracks. The result is shown against the budget, so leaders can see which parts of the study over- or under-perform.
Screen failures often pay a different rate than completed visits, and some budgets pay for only a set number of them. A study with many screen failures can lose money even when every visit is billed. Tracking them by study and by reason shows whether the issue is the protocol, the referral source or the budget the site agreed to.
Analytics can count trial claims Medicare returned as unprocessable, grouped by study and by error. A claim missing the NCT number comes back with CARC 16, MA50 and MA130, and a Q1 claim missing Z00.6 comes back with CARC 16 and M76. Seeing them by study points straight to the study whose billing setup needs a fix.
Sponsor payment timing is tracked from each invoice to the receipt that pays it. Trends by sponsor and CRO show which ones pay on their terms and which ones lag. That gives the research office facts to bring to the next budget talk, such as asking for more up-front money or shorter payment terms from a slow payer.
Medicare Advantage participants change the payer mix inside a study. For qualifying trials, Original Medicare pays routine costs for these enrollees, so their claims go to the MAC, not the plan. IDE study claims go to the plan instead. Payer mix by study keeps those groups apart, so expected and actual payers can be compared.
Related Clinical Research Software
Analytics & value-based care
In the revenue cycle
Analytics for related specialties
Sources
- CMS Medicare Claims Processing Manual, Chapter 32, Section 69: Qualifying Clinical Trials
- 42 U.S.C. 300gg-8: Coverage for individuals participating in approved clinical trials
- CMS State Medicaid Director Letter 21-005: Mandatory Medicaid Coverage of Routine Patient Costs in Qualifying Clinical Trials
- CMS Medicare Managed Care Manual, Chapter 4, Section 10.7: Clinical Trials
- CMS: Coverage with Evidence Development
GET STARTED
See Unlimited Systems in Action
Whether you're actively evaluating new technology or simply preparing for your next vendor renewal, Unlimited Systems can help you understand where your current workflows may be creating avoidable revenue risk.


